2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Entos Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA COVIGENIX VAX- 002 - COVID-19 | Phase 1 / Phase 2 | Completed | Entos Pharmaceuticals Inc. | 46 | 2024-07-22 | 2025-12-16 |
| A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults Covigenix VAX-001 placebo, Covigenix VAX-001 - SARS-CoV-2 | Phase 1 / Phase 2 | Completed | Entos Pharmaceuticals Inc. | 268 | 2021-04-07 | 2024-02-20 |
COVID-19 (2)
Canada (2) · Burkina Faso (1) · Senegal (1) · South Africa (1)